Tests involving D-dimer, prothrombin fragment F1 + 2, and left-ventricular ejection fraction (LVEF) can be useful in verifying hypercoagulability in patients with AF who are undergoing DOAC treatment. Here, F2 is linked to atrial fibrillation.